URL of this page: https://medlineplus.gov/genetics/gene/slc17a5/

SLC17A5 gene

solute carrier family 17 member 5
From Genetics Home Reference. Learn more

Normal Function

The SLC17A5 gene provides instructions for producing a protein called sialin that is located mainly on the membranes of lysosomes, compartments in the cell that digest and recycle materials. Sialin moves a molecule called free sialic acid, which is produced when certain proteins and fats are broken down, out of the lysosomes to other parts of the cell. Free sialic acid means that the sialic acid is not attached (bound) to other molecules.

Researchers believe that sialin may also have other functions in brain cells, in addition to those associated with the lysosomes, but these additional functions are not well understood.

Health Conditions Related to Genetic Changes

Sialic acid storage disease

Approximately 20 mutations that cause sialic acid storage disease have been identified in the SLC17A5 gene. Some of these mutations result in sialin that does not function normally; others prevent sialin from being produced. In a few cases, sialin is produced but not routed properly to the lysosomal membrane.

There are three forms of sialic acid storage disease. A particular SLC17A5 mutation, found primarily in people from Finland and Sweden, causes the least severe form of this disorder known as Salla disease. This mutation replaces the protein building block (amino acid) arginine with the amino acid cysteine at position 39 of the sialin protein (written as Arg39Cys or R39C). Other SLC17A5 gene mutations that have more damaging effects on sialin protein function cause the most severe form of the disorder, infantile free sialic acid storage disease. Individuals diagnosed with intermediate severe Salla disease have one copy of the SLC17A5 gene with the Salla disease mutation in each cell, while the second copy of the gene bears a more severe mutation. The severity of signs and symptoms of intermediate severe Salla disease falls between those of Salla disease and infantile free sialic acid storage disease.

SLC17A5 gene mutations that reduce or eliminate sialin activity result in a buildup of free sialic acid in the lysosomes. It is not known how this buildup, or disruption of other possible functions of sialin in the brain, causes the specific signs and symptoms of sialic acid storage disease.

More About This Health Condition

Other Names for This Gene

  • AST
  • ISSD
  • NSD
  • S17A5_HUMAN
  • SD
  • SIALIN
  • SIASD
  • SLD
  • solute carrier family 17 (acidic sugar transporter), member 5
  • solute carrier family 17, member 5

Additional Information & Resources

Tests Listed in the Genetic Testing Registry

Scientific Articles on PubMed

Catalog of Genes and Diseases from OMIM

Research Resources

References

  • Aula N, Kopra O, Jalanko A, Peltonen L. Sialin expression in the CNS implicates extralysosomal function in neurons. Neurobiol Dis. 2004 Mar;15(2):251-61. Citation on PubMed
  • Eskelinen EL, Tanaka Y, Saftig P. At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol. 2003 Mar;13(3):137-45. Review. Citation on PubMed
  • Mach L. Biosynthesis of lysosomal proteinases in health and disease. Biol Chem. 2002 May;383(5):751-6. Review. Citation on PubMed
  • Morin P, Sagné C, Gasnier B. Functional characterization of wild-type and mutant human sialin. EMBO J. 2004 Nov 24;23(23):4560-70. Epub 2004 Oct 28. Citation on PubMed or Free article on PubMed Central
  • Suwannarat P. Disorders of free sialic acid. Mol Genet Metab. 2005 Jun;85(2):85-7. Review. Citation on PubMed
From Genetics Home Reference

Genetics Home Reference has merged with MedlinePlus. Genetics Home Reference content now can be found in the "Genetics" section of MedlinePlus. Learn more

The resources on this site should not be used as a substitute for professional medical care or advice. Users with questions about a personal health condition should consult with a qualified healthcare professional.